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Abstract
Nutritional support has become an important intervention for critically ill patients. Many studies have reported on the effects of
nutritional support for the patients within the intensive care unit (ICU); however, no studies have speciﬁcally assessed patients with
gastrointestinal diseases who may have difﬁculty absorbing enteral nutrition (EN) in the ICU.
Sixty-two patients with gastrointestinal disease were admitted to the ICU between August 2014 and August 2016 at a single
tertiary university hospital. We analyzed 2 different patient groups in a retrospective cohort study: those who received nutritional
support team (NST) intervention and those who did not.
Forty-four (71.0%) patients received nutritional support in ICU and 18 (29.0%) did not. Variables includingmale sex, high albumin or
prealbumin level at the time of ICU admission, and short transition period into EN showed statistically signiﬁcant association with
lower mortality on the univariate analysis (all P< .05). Multivariate analysis revealed that longer length of hospital stay (P= .013; hazard
ratio [HR], 0.972; 95% conﬁdence interval [CI], 0.951–0.994), shorter transition into EN (P= .014; HR, 1.040; 95% CI, 1.008–1.072),
higher prealbumin level (P= .049; HR, 0.988; 95% CI, 0.976–1.000), and NST intervention (P= .022; HR, 0.356; 95% CI, 0.147–
0.862) were independent prognostic factors for lower mortality.
In conclusion, NST intervention related to early initiated EN, and high prealbumin levels are beneﬁcial to decrease mortality in the
acutely ill patients with GI disease.
Abbreviations: BMI = body mass index, CI = conﬁdence interval, EN = enteral nutrition, GI = gastrointestinal, HR = hazard ratio,
ICU = intensive care unit, IQR = interquartile range, LOS = length of stay, NRS = nutritional risk screening, NS = nutritional support,
NST = nutritional support team, PN = parenteral nutrition, SNSI = severance nutrition screening index.
Keywords: gastrointestinal disease, intensive care unit, nutritional support team, prognostic factor1. Introduction
Nutritional support (NS) has received increasing attention and
is now considered a crucial intervention for critically ill
patients,[1] who are commonly described as patients with
systemic inﬂammatory diseases accompanied by dysfunction ofEditor: Marcello Iriti.
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1multiple organs, extended hospital stay, increased morbidity
due to infection, and even mortality.[2] NS for critically ill
patients is conventionally seen as supplemental care for the
purpose of providing exogenous fuels to maintain lean body
mass and supporting the patient during a stress response. In
recent years, many advances have been made to nutrition
therapy, and feeding is thought to help prevent oxidative
cellular injury, lessen the metabolic response to stress, and
favorably regulate immune responses.[2] Sigalet et al summa-
rized the mechanistic relationships between enteral feeding
(EN) and immunity.[3] In addition, they reported that extensive
immunological changes within the bowel system, including the
population of immune cells, cytokine proﬁle, and secretory IgA
production, can be accomplished by nutrition support with
total parenteral nutrition. Among the available routes, EN has
gained favor due to the fact that it can be used to provide
metabolic substrates and possibly adjust the role of the
gastrointestinal (GI) tract in the systemic inﬂammatory
response[4,5] by enabling our body to keep the nonspeciﬁc
immune barriers in the enteric system which include enter-
ocytes, local microﬂora, tight junctions, gut-associated lym-
phoid tissue, and systemic immunity through extraintestinal
mucosa-associated lymphoid tissue.[3] Early EN, appropriate
macro- and micronutrient delivery, and meticulous glycemic
control can improve the clinical course of critical illness.[2] A
proactive therapeutic strategy to provide early nutrition
support, mainly by the enteral route, may decrease disease
severity, reduce complications, shorten length of stay (LOS) in
Figure 1. Flow diagram of patient enrollment. A total of 127 patients admitted
to the ICU for GI disease, and 65 patients were excluded. Finally, 62 patients
were selected for the statistical analysis. GI=gastrointestinal, ICU= intensive
care unit.
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outcomes.[2]
Several previous studies have shown the effects of nutritional
support on clinical outcomes for patients at nutritional risk,[6,7]
thus demonstrating the importance of useful nutritional
parameters and a nutritional support team (NST) approach to
avoid the risk of malnutrition[1,8] in critically ill patients within
the ICU.NST as a standardized feeding approach has been shown
to both increase appropriate macro- and micronutrient delivery
and minimize risks.[9,10] As an example, a decision-tree format
was utilized by Schwartz[11] as a method to improve interdisci-
plinary performances through communicating NS strategies to
clinicians in their local hospitals. This approach improved NS
practice, which lead to cost savings and quality improvement. As
far as we know, however, no studies have focused on the impact
and outcomes of NST intervention in patients with GI disease in
the ICU. Nutritional intake is pivotal and needs to be carefully
managed through EN, especially for patients with GI bleeding,
acute pancreatitis, inﬂammatory bowel disease, and GI malig-
nancy who are at greater risk of nutritional deﬁciency.[2,12] The
present study was designed to evaluate the effect of NST
intervention on clinical outcomes in patients with GI disease in
the ICU.2. Materials and methods
2.1. Patients
Between August 2014 and August 2016, we retrospectively
reviewed 15,178 ﬁles of patients admitted to the ICU at the
Severance Hospital, Yonsei University College of Medicine,
Seoul, Korea. Among them, 127 patients admitted to the ICU for
GI diseases, and 65 patients were excluded from our study for the
reasons following; transferred to other departments during ICU
admission (n=32); required surgery and postoperative care (n=
5); and expired within 7 days (n=28) (Fig. 1). Finally, 62 patients
were selected. All patients admitted to the ICU are routinely
subject to NST collaboration.
The NST has been reimbursed since August 2014, when the
national insurance for NST was initiated in Korea. From July
2015 to February 2016, NST activity had been temporarily
suspended due to personnel shortages at the hospital, and the
patients admitted to ICU at that time were classiﬁed as the control
group. This study was performed in accordance with the ethical
guidelines of the 1975 Declaration of Helsinki and approved by
the institutional review board of Severance Hospital.2.2. Baseline characteristics
The baseline characteristics of the patients were obtained,
including demographics; comorbidities; body mass index
(BMI); ventilator care; transition period into EN; nutritional
requirements including total calories (kcal/d), protein, and real
nutritional supplement at ICU admission; nutritional risk;
laboratory ﬁndings such as serum albumin, protein, glucose,
and prealbumin levels; length of ICU stay; and mortality.2.3. Nutritional support team
Our hospital has a NST consisting of nurses, dietitians,
pharmacists, and physicians.[13] They are specialized for
advanced nutritional assessment including proper nutritional
risk and counseling. Especially when the patients are admitted to2ICU, they are required to consult with NST, and the dietitians
attend the rounding every morning to identify the patients.
Therefore, when the physicians consult with NST, nurse,
dietitian, pharmacist, and specialized physicians, speciﬁc ques-
tions such as the nutritional requirement and recommendation
for proper ﬂuid, nutrients, and proper timing to EN could be
answered quickly. We strictly followed the protocols and applied
them to the patients.[13,14]2.4. Nutritional risk screening
2.4.1. NRS-2002. To evaluate nutritional risk, we used the
Nutritional Risk Screening (NRS)-2002, which is recommended
by the European Society of Parenteral and Enteral Nutrition for
nutritional screening in hospitalized patients.[15] Following the
protocols from the NRS-2002, all the patients were examined for
nutritional status and disease severity within 24hours after
admission. Calculations for the NRS score were performed by
summation of the nutritional status score of 0 to 3 and the
severity of disease score of 0 to 3, and additional 1 point was
added for patients who were ≥70 years.[15] The 3 determinants of
the nutritional status score are the quartiles of diminished oral
food intake in the week before admission, a low BMI score with
compromised condition in general, and weight loss of at least 5%
during the past 1 to 3 months. The severity of disease status was
classiﬁed as none, slight, moderate, or severe with scores of 0 to 3,
respectively. The total NRS score ranges from 0 to 7. According
to recommendations by Kondrup et al, anNRS score≥3 indicates
a patient who is nutritionally at risk, and a NRS score <3 means
there is no nutritional risk.[7,15]
2.4.2. Severance nutrition screening index. The severance
nutrition screening index (SNSI) is a new nutrition screening tool
and validated for 2 medical and 2 surgical wards patients for use
in tertiary hospitals.[16] The SNSI was calculated as follows:
SNSI=1.5albumin+1.0BMI+4.5 intake change+1.5
weight loss (for albumin <3.0, BMI <20, and decreased intake
and weight loss >5% of usual body weight) (Table 1).
Intake change was scored as 1 (no change or increase in intake)
or 2 (decrease). Weight loss was determined by using the previous
month’s weight as the base and scored as 1 (no change, increased
or decrease <5% of usual body weight) or 2 (decrease ≥5%).
Serum albumin was scored as 1 (≥3.5g/dL) or 2 (<3.5g/dL) and
BMI as 1 (≥20kg/m2) or 2 (<20kg/m2) (Table 1).[16]
Table 1
Model of the newly developed SNSI[16].
Variable Value
SNSI Model= (1.5 s-alb)+ (1.0 BMI)+ (4.5 food intake change)
+ (1.5 weight change)
Albumin, g/dL ≥3.5=1, <3.5=2
BMI, kg/m2 ≥20=1, <20=2
Food intake change No change or increase=1, decrease=2
Weight change No change, increase, or decrease <5% of usual body
weight=1, decrease ≥5%=2
BMI=body mass index, s-alb= serum albumin, SNSI= severance nutrition screening index.
Park et al. Medicine (2017) 96:49 www.md-journal.com2.4.3. Statistical analysis. Variables are expressed as median
(interquartile range, IQR) or n (%). The baseline characteristics
were compared using independent Student t tests (or Mann–
Whitney U tests) for continuous variables, and chi-squared tests
(or Fisher exact tests) were used for categorical variables, as
appropriate. The overall survival rates were analyzed using the
Kaplan–Meier method and compared with log-rank tests.
Independent predictors of mortality were analyzed using Cox
proportional hazard regression analysis. Hazard ratios (HRs)
and the corresponding 95% conﬁdence intervals (CIs) were
calculated. Data analysis was performed with SPSS software
(version 20.0; SPSS Inc., Armonk, NY). A P-value <.05 was
considered statistically signiﬁcant.Table 2
Clinical characteristics of GI patients in the ICU.
Variables
Total
(n=62)
Male sex, n (%) 40 (64.5)
Age, y 68 (58–75)
BMI, kg/m2 22.9 (20.3–25.8)
Underlying disease, n (%)
Hypertension 30 (48.4)
Diabetes 31 (50.0)
Hepatitis 14 (22.6)
Ventilator care, n (%) 40 (64.5)
Length of ICU stay, d 7 (3–11)
Laboratory ﬁndings
Albumin at ICU admission, g/dL 2.6 (2.3–2.9)
Albumin at ICU discharge, g/dL 2.7 (2.4–3.0)
Protein at ICU admission, g/dL 5.1 (4.7–6.0)
Protein at ICU discharge, g/dL 5.3 (4.7–6.0)
Glucose at ICU admission, mg/dL 163 (117–228)
Glucose at ICU discharge, mg/dL 138 (112–178)
Cholesterol, mg/dL 96 (78–130)
Prealbumin, mg/L 90 (75–120)
Number of patients who have stopped
feeding, n (%)
58 (93.5)
Nutritional requirements
Total kcal/d 1431 (1300–1600)
Protein, g 62 (53–71)
Nutritional supplement at ICU admission
Total kcal/d 340 (284–955)
Protein, g 18 (0–49)
Carbohydrate, g 100 (50–100)
Lipid, g 41 (34–45)
NRS-2002 4 (3–5)
SNSI 11.0 (10.0–14.5)
Data are expressed as median (interquartile range) or n (%).
BMI=body mass index, GI=gastrointestinal, ICU= intensive care unit, NRS=nutritional risk screening,
∗
P-value for comparing patients with NST group and no intervention group.
33. Results
3.1. Patient characteristics
A total of 62 patients were admitted to the ICU via the GI
department between August 2014 and August 2016. The median
age (64 years [IQR, 55–74] vs 71 years [IQR, 61–76]), male sex
(68.2% vs 55.6%), BMI (22.7kg/m2 [IQR, 20.1–26.0] vs 23.9kg/
m2 [IQR, 20.5–25.9]), and laboratory ﬁndings at ICU admission
and at discharge from the ICU were not signiﬁcantly different
between theNST interventiongroup (n=44) and the control group
(n=18) (all P> .05). Nutritional risk screening tools such as the
median NRS-2002 score (P= .628, 4.0 [IQR, 3–5] vs 4.0 [IQR, 3–
5]) and SNSI score (P= .416, 11.0 [IQR, 10.0–14.5] vs 13.0 [IQR,
10.0–14.7]) did not reveal signiﬁcant differences between the
groups. Additionally, the nutritional requirements including EN
and parenteral nutrition (PN) were high for both the NST
intervention group and control group (1400kcal/d [IQR, 1300–
1600] vs 1489kcal/d [IQR, 1310–1646], P= .695). The actual
nutritional supplementation at ICU admission was low for both
group (355kcal/d [IQR, 206–930] vs 340kcal/d [IQR 330–1048],
P= .900). Other baseline characteristics were not signiﬁcantly
different between the 2 groups (Table 2).
3.2. Reasons for ICU admission for GI patients
The most common reason for ICU admission was septic shock
(43.5%), followed by GI bleeding (38.7%), liver-related causeNST group
(n=44, 71.0%)
No intervention group
(n=18, 29.0%) P-value
∗
30 (68.2) 10 (55.6) .346
64 (55–74) 71 (61–76) .121
22.7 (20.1–26.0) 23.9 (20.5–25.9) .111
18 (40.9) 12 (66.7) .065
23 (52.3) 8 (44.4) .576
9 (20.5) 5 (27.8) .531
28 (63.6) 12 (66.7) .821
7 (3–13) 7 (3–10) .485
2.6 (2.3–3.0) 2.6 (2.3–2.9) .426
2.7 (2.4–3.1) 2.7 (2.3–2.9) .307
5.1 (4.8–6.0) 5.1 (4.5–6.4) .989
5.2 (4.7–6.1) 5.4 (4.8–5.9) .892
163 (116–251) 157 (125–200) .283
140 (111–183) 131 (113–163) .702
97 (76–139) 94 (76–126) .552
90 (71–120) 90 (83–116) .642
41 (93.2) 17 (94.4) .854
1400 (1300–1600) 1489 (1310–1646) .695
63 (52–75) 61 (53–66) .097
355 (206–930) 340 (330–1048) .900
29 (0–49) 22 (0–49) .129
100 (74–100) 100 (50–103) .787
41 (34–42) 45 (7–45) .568
4 (3–5) 4 (3–5) .628
11.0 (10.0–14.5) 13.0 (10.0–14.7) .416
NST=nutritional support team, SNSI= severance nutrition screening index.
Table 3
Reasons for ICU admission for GI patients.
Variable
Total
(n=62)
NST group
(n=44, 71.0%)
Control group
(n=18, 29.0%) P-value
∗
Reasons for ICU
admission
.104
GI bleeding 24 (38.7) 20 (45.5) 4 (22.2)
Liver-related
causes
8 (12.9) 3 (6.8) 5 (27.8)
Septic shock 27 (43.5) 19 (43.2) 8 (44.4)
Others (seizure,
perforation)
3 (4.8) 2 (4.5) 1 (5.6)
Data are expressed as n (%).
GI=gastrointestinal, ICU= intensive care unit, NST=nutritional support team.
∗
P-value for comparing patients with NST group and no intervention group.
Table 5
Relative risk of mortality.
Variable
Univariate analysis Multivariate analysis
P-value HR (95% CI) P-value
Adjusted
HR (95% CI)
Male sex .039 0.486 (0.245–0.964) .459 0.740 (0.333–1.645)
Age, y .298 1.015 (0.987–1.043) .472 1.014 (0.976–1.053)
BMI, kg/m2 .553 0.981 (0.921–1.045) .511 0.978 (0.915–1.045)
Length of ICU stay, d .397 1.011 (0.985–1.039)
Length of hospital
stay
.204 0.990 (0.974–1.006) .013 0.972 (0.951–0.994)
Transition period
into EN
.034 1.023 (1.002–1.046) .014 1.040 (1.008–1.072)
Ventilator care .374 1.390 (0.673–2.871)
Underlying disease
Hypertension .120 1.741 (0.866–3.501)
Diabetes .746 1.120 (0.564–2.225)
Hepatitis .734 1.148 (0.518–2.546)
Laboratory ﬁndings
Albumin at ICU
admission, g/dL
.043 0.513 (0.268–0.981) .427 0.703 (0.294–1.677)
Albumin at ICU .921 0.959 (0.415–2.216)
Park et al. Medicine (2017) 96:49 Medicine(12.9%), and others including seizure, perforation (4.8%)
(Table 3). The reasons for ICU admissions were not signiﬁcantly
different between the NST and control groups (P= .104)discharge, g/dL
Protein at ICU
admission, g/dL
.527 0.899 (0.647–1.250)
Protein at ICU
discharge, g/dL
.871 1.033 (0.695–1.536)
Glucose at ICU
admission, mg/dL
.381 0.998 (0.995–1.002)
Glucose at ICU
discharge, mg/dL
.137 1.003 (0.999–1.006)3.3. Diagnosis for patients in the ICU
We evaluated the primary diagnoses of all patients in our study
population. The most common was malignancy (38.7%),
followed by liver cirrhosis (38.7%), inﬂammation (pancreatitis,
colitis, cholangitis, and liver abscess) (11.3%), peptic ulcer
disease (8.1%), and intestinal perforation or stricture (3.2%)
(Table 4).Cholesterol, mg/dL .257 0.995 (0.986–1.004)
Prealbumin, mg/L .022 0.988 (0.978–0.998) .049 0.988 (0.976–1.000)
Diagnosis of ICU patients
Cancer .218 1.0 (Ref.)
Liver cirrhosis .168 0.589 (0.278–1.249)
Inﬂammation .125 0.316 (0.072–1.377)
Other .162 0.414 (0.120–1.427)3.4. Relative risk of mortality
On the univariate analysis, variables including male sex (HR,
0.486; 95% CI, 0.245–0.964; P= .039), longer transition period
into EN (HR, 1.023; 95% CI, 1.002–1.046; P= .034), lowerTable 4
Diagnoses for patients in the ICU.
Variable
Total
(n=62)
NST
intervention
group
(n=44,
71.0%)
Control
group
(n=18,
29.0%) P-value
∗
Malignancy, n (%) 24 (38.7) 19 (43.2) 5 (27.8) .258
Hepatocellular carcinoma 9 (14.5) 7 (15.9) 2 (11.1)
Pancreatic cancer 8 (12.9) 6 (13.6) 1 (5.6)
Cholangiocarcinoma 1 (1.6) 0 (0) 1 (5.6)
Gallbladder cancer 1 (1.6) 1 (2.3) 0 (0)
Esophageal cancer 1 (1.6) 1 (2.3) 0 (0)
Stomach cancer 2 (3.2) 3 (6.8) 0 (0)
Colon cancer 2 (3.2) 1 (2.3) 1 (5.6)
Liver cirrhosis, n (%) 24 (38.7) 16 (36.4) 8 (44.4) .553
Inﬂammation, n (%) 7 (11.3) 3 (6.8) 4 (22.2) .082
Pancreatitis 2 (3.2) 0 (0) 2 (11.1)
Colitis 3 (4.8) 2 (4.5) 1 (5.6)
Cholangitis 1 (1.6) 1 (2.3) 0 (0)
Liver abscess 1 (1.6) 0 (0) 1 (5.6)
Others, n (%) 7 (11.3) 6 (13.6) 1 (5.6) .361
Peptic ulcer disease 5 (8.1) 5 (11.4) 0 (0)
Intestinal perforation or stricture 2 (3.2) 1 (2.3) 1 (5.6)
Data are expressed as n (%).
ICU= intensive care unit, NST=nutritional support team.
∗
P-value for comparing patients with NST group and no intervention group.
NST .205 0.631 (0.309–1.286) .022 0.356 (0.147–0.862)
BMI=body mass index, CI=conﬁdence interval, EN= enteral nutrition, HR=hazard ratio, ICU=
intensive care unit, NST=nutritional support team.
4serum albumin at ICU admission (HR, 0.513; 95% CI, 0.268–
0.981; P= .043), and lower prealbumin levels (HR, 0.988; 95%
CI, 0.978–0.998; P= .022) were signiﬁcantly associated with
mortality risk (Table 5). On multivariate analysis, along with
variables including male sex, age, BMI, and albumin at the time
of ICU admission, we found that longer length of hospital stay
(adjusted HR, 0.972; 95% CI, 0.951–0.994; P= .013), shorter
transition period into EN (adjusted HR, 1.040; 95% CI, 1.008–
1.072; P= .014), high prealbumin levels (adjusted HR, 0.988;
95%CI, 0.976–1.000; P= .049), and NST intervention (adjusted
HR, 0.356; 95%CI, 0.147–0.862; P= .022) were associated with
lower mortality (Table 5).
Themedian follow-up periodwas 95 days (IQR, 20–490 days).
However, cumulative survival rate was not signiﬁcantly different
between NST group and control group (P= .199) (Fig. 2).
4. Discussion
Our results showed that patients with GI disease in the ICU who
had a longer hospital stay, shorter transition period into EN,
higher prealbumin level, and NST intervention had a lower
mortality. Patients in the ICU are sedated, ventilated, and
Figure 2. Cumulative survival rate between NST intervention group and control
group (Kaplan–Meier graph). NST=nutritional support team.
Park et al. Medicine (2017) 96:49 www.md-journal.comsufﬁciently disabled so that volitional oral feeding is either
impossible or unlikely to successfully meet nutrient require-
ments.[17] Additionally, critically ill patients often have more
risks for malnutrition, with high mortality and morbidity rates[8]
due to increased metabolic needs and the tendency for
underfeeding.[18] These factors can predispose to a systemic
inﬂammatory response, which increases muscle protein catabo-
lism and moderately increases energy expenditure.[19] Several
studies have shown favorable effects of NS for patients who are at
nutritional risk within the ICU.[6,7]
According to the systemic review from DeLegge and
Kelley,[14] many hospitals and other organizations in the
healthcare ﬁeld have been gradually reducing the number of
NSTs lately even with their proven efﬁcacy through literature,
because they try to ﬁnd ways to lower expenses. According to
the 2008 survey by the American Society for Parenteral and
Enteral Nutrition (ASPEN), only 42% of the respondents, who
practice in a hospital setting, reported that they had ofﬁcial
NSTs. This shows a gradual decrease, because 44%and 65%of
participants reported that they had formal NSTs in years 2005
and 1995, respectively.[20,21] Unlike this misconception with
formal NSTs causing increased costs with minimal beneﬁts,
many studies[22,23] actually showed that when a proper
management is done by an NST, there are signiﬁcant improve-
ments in the nutritional status of patients and in clinical
outcomes, and it even leads to reductions in the expenses for
hospitals.[14] Based on these ﬁndings, NST intervention for
critically ill patients with GI disease would be expected to
reduce mortality and morbidity. Martin et al[24] performed a
multicenter, cluster-randomized clinical trial that compared
characteristics between patients from 7 control hospitals (n=
214) and 7 nutrition intervention hospitals (n=248). Those
treated at intervention hospitals showed a trend toward reduced
mortality. Malnutrition is often accompanied by serious
clinical and other consequences which may include ﬁnancial
cost, extended LOS, infection, and increased morbidity and
mortality rates.[25–27] In addition, factors including late
initiation of EN, slow advancement of infusion rate, under-
prescription, dysfunction of gastrointestinal system, failure in
proper delivery of prescribed nutrition, and interruption of EN
may all lead to insufﬁcient enteral feeding.[25,28]5The Society of Critical Care Medicine (SCCM) and ASPEN
recently reported new guidelines for nutrition support therapy in
critically ill adult patients.[2] They have suggested determining
nutrition risk using methods such as NRS-2002 for all patients
admitted to the ICU for whom volitional intake is anticipated to
be insufﬁcient. When screening methods identify patients at
nutritional risk, they should be transitioned to EN early.[2] In our
study population, the median NRS-2002 score was 4.0 (NRS
score ≥3, high risk), and most of them received PN at initial
admission in the ICU (n=56). On the multivariate analysis, a
longer transition period into EN was also determined to be an
independent risk factor for mortality. The reason for the small
number of patients (n=6) who received EN in the ICU at
admission was that most of patients suffered from GI bleeding
(n=24) or were intubated (n=40) when ﬁrst admitted. GI
bleeding can be caused by peptic ulcer disease, variceal bleeding,
and cancer bleeding, and EN is not recommended until it stops.
As important as EN duration, prealbumin level is the earliest
laboratory indicator of nutritional status and has emerged as the
preferred marker for malnutrition because it correlates with
patient outcomes in a wide variety of clinical conditions.[29]
Patients who need aggressive NS can be monitored using the
prealbumin level.[30] Our study conﬁrmed that prealbumin level
is an independent predictive factor of mortality and a useful
indicator for effects of NS.
As far as we know, this is the ﬁrst study to examine the impact
of NST intervention on patients with GI disease in the ICU.
Longer hospital stay, shorter transition period into EN, higher
prealbumin levels, and NST were independent factors of
reduced mortality. Our study also has limitations. Firstly, the
design was retrospective with a relatively small sample size and
heterogeneity of patients with diverse digestive system diagno-
ses who were treated at a single hospital which could leading to
selection bias[31,32] and weak statistical power. Retrospective
cohort study is not possible to establish causal effects caused by
confounders,[31] and our study populations were too small to
perform sensitivity analysis. Nevertheless, it is a large tertiary
hospital with >2400 beds. Additionally, our cohort research
design is unprecedented due to the unique hospital environment
allowing comparison of the effect of NST on ICU patients in 1
center. Therefore, although the statistical power is weak, our
study is meaningful to ﬁnd the NST related factors as an
exploratory purpose. Secondly, although we excluded patients
who died within 7 days, most of them still had a short median
length of ICU stay that hampered evaluation of the effect of
NST intervention. However, NST was found to be beneﬁcial
even with a small patient number and relatively short ICU stay.
This study, therefore, reminds GI physicians of the importance
of NST. Prospective studies with improved designs are
warranted to determine the effect of NST in patients with GI
diseases, not only in ICU but also in general wards and
outpatient clinics.5. Conclusion
In conclusion, our results demonstrate that longer hospital stay,
shorter transition period into EN, higher prealbumin levels, and
NST intervention were inﬂuencing factors for lower mortality in
patients with gastrointestinal disease in the ICU. This suggests
that acutely ill adult patients with GI disease should be properly
evaluated for nutrition risk, initiated early on EN, and undergo
NST intervention.
[16] Lee H, Shim H, Jang JY. Development of a new nutrition screening tool
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